A device called the Watchman— a left atrial appendage closure — gives people with atrial fibrillation an option other than taking blood-thinning drugs.
Legacy Health's Structural Heart Program was the first health care system in Oregon to offer the Watchman implant for patients with atrial fibrillation and those who want an alternative to blood-thinning drugs.
Amish J. Desai, MD, FACC, medical director of the Legacy Structural Heart Program, has participated in the clinical trials for the Watchman and has more than 10 years of experience using and implanting the device. Dr. Desai has performed more Watchman implant procedures than any doctor in the Pacific Northwest and is among the top 10 nationwide in the procedure.
Patients who may benefit from the Watchman:
If you have questions about the Watchman device, please call Legacy Medical Group-Cardiology at 503-413-4780.
The information provided here or on the Watchman website is not a substitute for talking with your doctor. Always talk with your doctor about your diagnosis and treatment options.
Referring physicians call 503-413-4831.
For some patients, strokes are caused by blood clots. Patients with Atrial Fibrillation (AFib) experience increased risk for blood clots because the heart quivers or "fibrillates," releasing only a portion of the blood. When this occurs, blood can collect in the heart and potentially form a clot. If this blood clot pumps out of the heart, to the brain, it can block off the blood supply to an artery in the brain, causing a stroke.
Patients with Atrial Fibrillation can learn more about the Watchman as an option to decrease their risk of a potentially dangerous blood clot that could cause a stroke.